You have 9 free searches left this month | for more free features.

N-Methyl-3,4-methylenedioxyamphetamine

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Healthy Trial in Basel (3,4-methylenedioxymethamphetamine, 3,4-methylenedioxyamphetamine,

Recruiting
  • Healthy
  • Basel, BS, Switzerland
    University Hospital Basel, Clinical Trial Unit
Dec 7, 2021

Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Philadelphia (Palbociclib, Tazemetostat,

Not yet recruiting
  • Recurrent Acute Myeloid Leukemia
  • Refractory Acute Myeloid Leukemia
  • Philadelphia, Pennsylvania
    Thomas Jefferson University Hospital
Jan 13, 2023

Depressive Disorder, Major, Bipolar Disorder, Post Traumatic Stress Disorder Trial in New Haven (Ketamine, Perampanel, Placebo)

Not yet recruiting
  • Depressive Disorder, Major
  • +2 more
  • New Haven, Connecticut
    Yale University
Jun 26, 2023

Depressive Disorder, Major, Bipolar Disorder, Post Traumatic Stress Disorder Trial in New Haven (Ketamine, Perampanel, Placebo)

Recruiting
  • Depressive Disorder, Major
  • +2 more
  • New Haven, Connecticut
    Yale University
Aug 8, 2022

Metastatic Uveal Melanoma Trial in Philadelphia (Defactinib Hydrochloride, Raf/MEK Inhibitor VS-6766)

Recruiting
  • Metastatic Uveal Melanoma
  • Defactinib Hydrochloride
  • +2 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Jan 23, 2023

Rhabdomyosarcoma Trial in Los Angeles (Vinorelbine, Mocetinostat)

Recruiting
  • Rhabdomyosarcoma
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
May 13, 2022

Oligometastatic Prostate Carcinoma, Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8 Trial in Decatur, Effingham,

Recruiting
  • Oligometastatic Prostate Carcinoma
  • +2 more
  • Placebo Administration
  • +3 more
  • Decatur, Illinois
  • +2 more
Aug 11, 2022

Thyroid Cancer, Anaplastic Thyroid Cancer, Undifferentiated Thyroid Cancer Trial in Stanford (Abemaciclib)

Active, not recruiting
  • Thyroid Cancer
  • +2 more
  • Stanford, California
    Stanford University
Nov 8, 2022

Stage IIC Prostate Cancer AJCC v8, Stage III Prostate Cancer AJCC v8, Stage IV Prostate Cancer AJCC v8 Trial in Kansas City

Not yet recruiting
  • Stage IIC Prostate Cancer AJCC v8
  • +2 more
  • Biospecimen Collection
  • +9 more
  • Kansas City, Kansas
    University of Kansas Cancer Center
Nov 3, 2023

Localized Osteosarcoma, Metastatic Osteosarcoma, Resectable Osteosarcoma Trial (Bone Scan, Cabozantinib S-malate, Cisplatin)

Not yet recruiting
  • Localized Osteosarcoma
  • +3 more
  • Cabozantinib S-malate
  • +7 more
  • (no location specified)
Jan 4, 2023

Atypical Endometrial Hyperplasia, Endometrial Carcinoma Trial in Duarte (Megestrol Acetate, Pterostilbene)

Recruiting
  • Atypical Endometrial Hyperplasia
  • Endometrial Carcinoma
  • Megestrol Acetate
  • Pterostilbene
  • Duarte, California
    City of Hope Medical Center
Oct 12, 2022

OCD Trial (3,4-Methyl enedioxy methamphetamine, Methamphetamine, Cognitive Behavioral Therapy (CBT))

Not yet recruiting
  • Obsessive-Compulsive Disorder
  • 3,4-Methyl enedioxy methamphetamine
  • +2 more
  • (no location specified)
Mar 28, 2023

Aging Trial in Glendale

Withdrawn
  • Aging
  • (1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol
  • Control
  • Glendale, Arizona
    Glencroft Senior Living: Retirement Community in Arizona
Jan 30, 2023

PTSD Trial in Vancouver (Placebo, 3,4-methylenedioxymethamphetamine, Psychotherapy)

Terminated
  • Posttraumatic Stress Disorder
  • Placebo
  • +2 more
  • Vancouver, British Columbia, Canada
    Offices of Dr. Ingrid Pacey MBBS FRCP[C]
Jun 14, 2022

Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Philadelphia (STAT

Active, not recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • STAT Inhibitor OPB-111077
  • +3 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Dec 20, 2022

Substance Use, Healthy Subjects Trial in Badalona (Methylone, 3,4-methylenedioxymethamphetamine, Placebo)

Active, not recruiting
  • Substance Use
  • Healthy Subjects
  • Badalona, Barcelona, Spain
    Germans Trias i Pujol Hospital
Aug 4, 2022

Diabetes Type 2 With Proteinuria, Diabetes, Type 2, Diabetes Trial (drug, device, diagnostic test, behavioral)

Not yet recruiting
  • Diabetes Mellitus Type 2 With Proteinuria
  • +12 more
  • Empagliflozin 10 MG
  • +6 more
  • (no location specified)
Oct 17, 2023

PTSD Trial (MDMA, Group Therapy)

Not yet recruiting
  • PTSD
  • (no location specified)
Jul 17, 2023

Myelodysplastic Syndrome, Recurrent Myelodysplastic Syndrome, Refractory Myelodysplastic Syndrome Trial in Philadelphia

Recruiting
  • Myelodysplastic Syndrome
  • +2 more
  • Navitoclax
  • +6 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Feb 2, 2023

Recurrent Acute Myeloid Leukemia Trial in Duarte (Bosutinib Monohydrate, Decitabine, Enasidenib Mesylate)

Withdrawn
  • Recurrent Acute Myeloid Leukemia
  • Bosutinib Monohydrate
  • +6 more
  • Duarte, California
    City of Hope Meidcal Center
Jun 7, 2022

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Breast Carcinoma Trial in

Not yet recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +14 more
  • Biopsy
  • +25 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Jul 12, 2022

Bipolar Disorder Trial in Canada (Cannabidiol, Placebo)

Not yet recruiting
  • Bipolar Disorder
  • Calgary, Alberta, Canada
  • +7 more
May 18, 2023

Advanced Malignant Solid Tumor, EGFR Gene Amplification, EGFR Gene Mutation Trial in Houston (Everolimus, Neratinib,

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +9 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 25, 2022

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome Trial in United States

Suspended
  • Acute Myeloid Leukemia
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
  • Los Angeles, California
  • +5 more
Dec 10, 2022

Recurrent Acute Myeloid Leukemia Trial in United States (Enasidenib Mesylate, Liposome-encapsulated Daunorubicin-Cytarabine)

Suspended
  • Recurrent Acute Myeloid Leukemia
  • Enasidenib Mesylate
  • Liposome-encapsulated Daunorubicin-Cytarabine
  • Los Angeles, California
  • +3 more
Sep 27, 2022